Carbapenem resistance and acquired class D beta-lactamases in Acinetobacter baumannii from Croatia 2009-2010

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 3, 2014, Pages 471-478

  Vranic Ladavac M ^a   Bedenic B ^b   Minandri, F ^c   Istok M ^b   Bosnjak Z ^d   Francula Zaninovic S ^e   Ladavac, R ^f   Visca, P ^c  

^a Istria County Public Health Institute   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c ROMA TRE UNIVERSITY   (Italy)

^d UNIVERSITY HOSPITAL OSIJEK   (Croatia)

^e Health Center Zagreb   (Croatia)

^f General Hospital   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAMASE; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BETA LACTAMASE GENE; CARBAPENEMASE GENE; CLONE; CONTROLLED STUDY; CROATIA; ENZYME SYNTHESIS; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; INTERNATIONAL CLONAL LINEAGE I; INTERNATIONAL CLONAL LINEAGE II; MAJOR CLINICAL STUDY; MICROBIAL POPULATION DYNAMICS; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; OXACILLINASE GENE; PREVALENCE; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CROATIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY;

EID: 84896728796     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-1991-9     Document Type: Article

References (42)

1. Dijkshoorn L, Nemec A, Seifert H (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5:939-951
2. Visca P, Seifert H, Towner KJ (2011) Acinetobacter infection-an emerging threat to human health. IUBMB Life 63:1048-1054
3. Towner KJ (2009) Acinetobacter: an old friend, but a new enemy. J Hosp Infect 4:355-363
4. Zarrilli R, Pournaras S, Giannouli M, Tsakris A (2013) Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 41:11-19
5. Poirel L, Bonnin RA, Nordmann P (2012) Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram-negative rods. Infect Genet Evol 12:883-893
6. Kempf M, Rolain JM (2012) Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents 39:105-114
7. Zarrilli R, Giannouli M, Tomasone F, Triassi M, Tsakris A (2009) Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities. J Infect Dev Ctries 3:335-341
8. Poirel L, Bonnin RA, Nordmann P (2011) Genetic basis of antibiotic resistance in pathogenic Acinetobacter species. IUBMB Life 63:1061-1067
9. Cornaglia G, Riccio ML, Mazzariol A, Lauretti L, Fontana R, Rossolini GM (1999) Appearance of IMP-1 metallo-β-lactamase in Europe. Lancet 353:899-900
10. Brown S, Amyes S (2006) OXA β-lactamase in Acinetobacter: the story so far. J Antimicrob Chemother 57:1-3
11. Bonnin RA, Nordmann P, Potron A, Lecuyer H, Zahar JR, Poirel L (2011) Carbapenem-hydrolyzing GES-type extended-spectrum beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 55:349-354
12. Poirel L, Nordmann P (2006) Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 12:826-836
13. Higgins P, Poirel L, Lehmann M, Nordmann P, Seifert H (2009) OXA-143, a novel carbapenem-hydrolyzing class D β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 53:5035-5038
14. OXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother 50:1442-1448
15. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, Pitt TL (2006) The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 258:72-77
16. OXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 16:35-40
17. Van Looveren M, Goossens H, ARPAC Steering Group (2004) Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect 10:684-704
18. Goic-Barisic I, Bedenic B, Tonkic M, Katic S, Kalenic S, Punda-Polic V (2007) First report of molecular characterization of carbapenem-resistant Acinetobacter baumannii in different intensive care units in University Hospital Split, Croatia. J Chemother 19:416-418
19. Goic-Barisic I, Bedenic B, Tonkic M, Novak A, Katic S, Kalenic S, Punda-Polic V, Towner KJ (2009) Occurrence of OXA-107 and ISAba1 in carbapenem-resistant isolates of Acinetobacter baumannii from Croatia. J Clin Microbiol 47:3348-3349
20. Goic-Barisic I, Towner KJ, Kovacic A, Sisko-Kraljevic K, Tonkic M, Novak A, Punda-Polic V (2011) Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase. J Hosp Infect 77:368-369
21. Franolić-Kukina I, Bedenić B, Budimir A, Herljević Z, Vraneš J, Higgins PG (2011) Clonal spread of carbapenem-resistant OXA-72-positive Acinetobacter baumannii in a Croatian university hospital. Int J Infect Dis 15:e706-e709
22. Schreckenberger PC, Daneshvar MI, Weyant RS, Hollis DG (2003) Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative Gram-negative rods. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds) Manual of Clinical Microbiology, 8th edn. American Society for Microbiology, Washington, D.C, pp 749-779
23. Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:309-332
24. Clinical and Laboratory Standards Institute (2013) Performance Standards for Antimicrobial Susceptibility Testing, M100-S23. Wayne, PA
25. Corvec S, Caroff N, Espaze E, Giraudeau C, Drugeon H, Reynaud A (2003) AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. J Antimicrob Chemother 52:629-635
26. Marchiaro P, Mussi MA, Ballerini V, Pasteran F, Viale AM, Vila AJ, Limansky AS (2005) Sensitive EDTA-based microbiological assays for detection of metallo-beta-lactamases in nonfermentative Gram-negative bacteria. J Clin Microbiol 43:5648-5652
27. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268-281
28. Arlet G, Brami G, Decre D, Flippo A, Gaillot O, Lagrange PH, Philippon A (1995) Molecular characterization by PCR restriction fragment polymorphism of TEM β-lactamases. FEMS Microbiol Lett 134:203-208
29. (SIM-1) in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 49:4485-4491
30. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM (2006) Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27(4):351-353
31. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL (2007) Use of sequence based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect 13:807-815
32. Grundmann HJ, Towner KJ, Dijkshoorn L, Gerner-Smidt P, Maher M, Seifert H, Vaneechoutte M (1997) Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J Clin Microbiol 35:3071-3077
33. Spence RP, Towner KJ, Henwood CJ, James D, Woodford N, Livermore DM (2002) Population structure and antibiotic resistance of Acinetobacter DNA group 2 and 13TU isolates from hospitals in the UK. J Med Microbiol 51:1107-1112
34. Towner KJ, Levi K, Vlassiadi M, Steering Group ARPAC (2008) Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe. Clin Microbiol Infect 14:16-167
35. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S (2010) The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS ONE 5:e10034
36. Karageorgopoulos DE, Falagas ME (2008) Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 8:751-762
37. Livermore DM, Walsh TR, Toleman M, Woodford N (2011) Balkan NDM-1: escape or transplant? Lancet Infect Dis 11:164
38. Karah N, Sundsfjord A, Towner K, Samuelsen Ø (2012) Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat 15:237-247
39. OXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother 51:1530-1533
40. Nemec A, Krízová L, Maixnerová M, Diancourt L, van der Reijden TJ, Brisse S, van den Broek P, Dijkshoorn L (2008) Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother 62:484-489
41. D'Arezzo S, Capone A, Petrosillo N, Visca P, GRAB (2009) Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy). Clin Microbiol Infect 15:347-357
42. D'Arezzo S, Principe L, Capone A, Petrosillo N, Petrucca A, Visca P (2011) Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J Antimicrob Chemother 66:54-61